An official website of the United States government
Abstract The microglial surface protein Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) plays a critical role in mediating brain homeostasis and inflammatory responses in Alzheimer’s disease (AD). The soluble form of TREM2 (sTREM2) exhibits neuroprotective effects in AD, though the underlying mechanisms remain elusive. Moreover, differences in ligand binding between TREM2 and sTREM2, which have major implications for their roles in AD pathology, remain unexplained. To address these knowledge gaps, we conducted the most computationally intensive molecular dynamics simulations to date of (s)TREM2, exploring their interactions with key damage- and lipoprotein-associated phospholipids and the impact of the AD-risk mutation R47H. Our results demonstrate that the flexible stalk domain of sTREM2 serves as the molecular basis for differential ligand binding between sTREM2 and TREM2, facilitated by its role in stabilizing the Ig-like domain and altering the accessibility of canonical ligand binding sites. We identified a novel ligand binding site on sTREM2, termed the ‘Expanded Surface 2’, which emerges due to competitive binding of the stalk with the Ig-like domain. Additionally, we observed that the stalk domain itself functions as a site for ligand binding, with increased binding in the presence of R47H. This suggests that sTREM2’s neuroprotective role in AD may, at least in part, arise from the stalk domain’s ability to rescue dysfunctional ligand binding caused by AD-risk mutations. Lastly, our findings indicate that R47H-induced dysfunction in membrane-bound TREM2 may result from both diminished ligand binding due to restricted complementarity-determining region 2 loop motions and an impaired ability to differentiate between ligands, proposing a novel mechanism for loss-of-function. In summary, these results provide valuable insights into the role of sTREM2 in AD pathology, laying the groundwork for the design of new therapeutic approaches targeting (s)TREM2 in AD.
more »
« less
Plasmonic Interferometers as TREM2 Sensors for Alzheimer’s Disease
We report an effective surface immobilization protocol for capture of Triggering Receptor Expressed on Myeloid Cells 2 (TREM2), a receptor whose elevated concentration in cerebrospinal fluid has recently been associated with Alzheimer’s disease (AD). We employ the proposed surface functionalization scheme to design, fabricate, and assess a biochemical sensing platform based on plasmonic interferometry that is able to detect physiological concentrations of TREM2 in solution. These findings open up opportunities for label-free biosensing of TREM2 in its soluble form in various bodily fluids as an early indicator of the onset of clinical dementia in AD. We also show that plasmonic interferometry can be a powerful tool to monitor and optimize surface immobilization schemes, which could be applied to develop other relevant antibody tests.
more »
« less
- Award ID(s):
- 1842605
- PAR ID:
- 10312878
- Date Published:
- Journal Name:
- Biosensors
- Volume:
- 11
- Issue:
- 7
- ISSN:
- 2079-6374
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
DeMartino, George (Ed.)Tauopathies are neurodegenerative disorders characterized by the deposition of aggregates of the microtubule-associated protein tau, a main component of neurofibrillary tangles. Alzheimer’s disease (AD) is the most common type of tauopathy and dementia, with amyloid-beta pathology as an additional hallmark feature of the disease. Besides its role in stabilizing microtubules, tau is localized at postsynaptic sites and can regulate synaptic plasticity. The activity-regulated cytoskeleton-associated protein (Arc) is an immediate early gene that plays a key role in synaptic plasticity, learning, and memory. Arc has been implicated in AD pathogenesis and regulates the release of amyloid-beta. We found that decreased Arc levels correlate with AD status and disease severity. Importantly, Arc protein was upregulated in the hippocampus of Tau KO mice and dendrites of Tau KO primary hippocampal neurons. Overexpression of tau decreased Arc stability in an activity-dependent manner, exclusively in neuronal dendrites, which was coupled to an increase in the expression of dendritic and somatic surface GluA1-containing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. The tau-dependent decrease in Arc was found to be proteasome-sensitive, yet independent of Arc ubiquitination and required the endophilin-binding domain of Arc. Importantly, these effects on Arc stability and GluA1 localization were not observed in the commonly studied tau mutant, P301L. These observations provide a potential molecular basis for synaptic dysfunction mediated through the accumulation of tau in dendrites. Our findings confirm that Arc is misregulated in AD and further show a physiological role for tau in regulating Arc stability and AMPA receptor targeting.more » « less
-
Abstract Despite extensive efforts on probing the mechanism of Alzheimer’s disease (AD) and enormous investments into AD drug development, the lack of effective disease-modifying therapeutics and the complexity of the AD pathogenesis process suggest a great need for further insights into alternative AD drug targets. Herein, we focus on the chiral effects of truncated amyloid beta (Aβ) and offer further structural and molecular evidence for epitope region-specific, chirality-regulated Aβ fragment self-assembly and its potential impact on receptor-recognition. A multidimensional ion mobility-mass spectrometry (IM-MS) analytical platform and in-solution kinetics analysis reveal the comprehensive structural and molecular basis for differential Aβ fragment chiral chemistry, including the differential and cooperative roles of chiral Aβ N-terminal and C-terminal fragments in receptor recognition. Our method is applicable to many other systems and the results may shed light on the potential development of novel AD therapeutic strategies based on targeting the D-isomerized Aβ, rather than natural L-Aβ.more » « less
-
It has been reported in photodoping experiments that localized surface plasmonic resonances can be sustained with electrons as few as 3. We performed first principles calculations of density functional theory, with the Hubbard U correction, to see if localized surface plasmonic resonances can also be sustained by doping a wide bandgap ZnO with few shallow donors of Ga. We distributed 3–6 dopants approximately uniformly, due to quasi-spherical geometry of the quantum dot, in the dilute doping limit. The uniform distribution of dopants in quantum dots has been reported experimentally. Although the dopant configurations are limited due to computational cost, our findings shed light on absorption trends. Results for quantum dots of 1.4 nm, passivated with pseudo-hydrogens, show that localized surface plasmonic resonances can be generated in the near infrared range. The absorption linewidths for such small-sized quantum dots are broad. We find that the resonance linewidth depends on the orientation of surfaces and the number of secondary peaks on the concentration of dopants. The absorption coefficients, as functions of the principal values of the dielectric tensor, indicate that an electric field with orientation parallel to that of the most symmetric surface will produce localized surface plasmonic resonances with high quality factors.more » « less
-
Abstract The visualization of pure phase objects by wavefront sensing has important applications ranging from surface profiling to biomedical microscopy, and generally requires bulky and complicated setups involving optical spatial filtering, interferometry, or structured illumination. Here we introduce a new type of image sensors that are uniquely sensitive to the local direction of light propagation, based on standard photodetectors coated with a specially designed plasmonic metasurface that creates an asymmetric dependence of responsivity on angle of incidence around the surface normal. The metasurface design, fabrication, and angle-sensitive operation are demonstrated using a simple photoconductive detector platform. The measurement results, combined with computational imaging calculations, are then used to show that a standard camera or microscope based on these metasurface pixels can directly visualize phase objects without any additional optical elements, with state-of-the-art minimum detectable phase contrasts below 10 mrad. Furthermore, the combination of sensors with equal and opposite angular response on the same pixel array can be used to perform quantitative phase imaging in a single shot, with a customized reconstruction algorithm which is also developed in this work. By virtue of its system miniaturization and measurement simplicity, the phase imaging approach enabled by these devices is particularly significant for applications involving space-constrained and portable setups (such as point-of-care imaging and endoscopy) and measurements involving freely moving objects.more » « less
- Free Publicly Accessible Full Text
-
Accepted Manuscript1.0
- Journal Article:
- https://doi.org/10.3390/bios11070217
